Search results for "cell therapy"

Muscle Loss Double-Whammy: Sarcopenia Triggers Faster Progression in Lung Cancer Patients on Immunotherapy

Muscle Loss Double-Whammy: Sarcopenia Triggers Faster Progression in Lung Cancer Patients on Immunotherapy

Muscle mass in lung cancer patients may play a decisive role in determining the success of immunotherapy. A new study indicates that patients with...
Radioembolization Extends Survival in Select Patients with Advanced Liver Cancer, Study Finds

Radioembolization Extends Survival in Select Patients with Advanced Liver Cancer, Study Finds

Hearing a doctor say that “the cancer has invaded the portal vein” can be deeply overwhelming for patients with liver cancer.
When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

When Other Biologics Fail: Skyrizi Drives Steroid-Free Remission in Over Half of Hard-to-Treat Crohn’s Patients

Crohn’s disease remains one of the most challenging inflammatory bowel diseases to manage.
Diabetes Drug Repurposed: Evogliptin Shows Promise in Preventing Disfiguring Burn Scars

Diabetes Drug Repurposed: Evogliptin Shows Promise in Preventing Disfiguring Burn Scars

Burn survivors frequently face a distressing secondary complication known as hypertrophic scarring, where the skin...
Mapping Cancer’s Footprint: Specialized PET/CT Scans Pinpoint Metastasis and Recurrence

Mapping Cancer’s Footprint: Specialized PET/CT Scans Pinpoint Metastasis and Recurrence

Following a cancer diagnosis, patients and their families almost invariably ask the same urgent question: “How far has...
Why Cutting Carbs Isn’t Enough: The Critical Link Between Circadian Stability and Glycemic Success

Why Cutting Carbs Isn’t Enough: The Critical Link Between Circadian Stability and Glycemic Success

For individuals living with diabetes, dietary choices are traditionally considered the most critical factor in health...
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological...
Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood

Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood

Curocell, a South Korean clinical-stage biotech company specializing in chimeric antigen receptor T-cell (CAR-T)...
RNA Therapy Emerges as Critical Fast-Track for Cholesterol Control After Heart Attacks

RNA Therapy Emerges as Critical Fast-Track for Cholesterol Control After Heart Attacks

Myocardial infarction and unstable angina are life-threatening medical emergencies that occur when the blood vessels...
Nasal Drug Delivery Shows Promise for Deadly Glioblastoma Brain Tumors

Nasal Drug Delivery Shows Promise for Deadly Glioblastoma Brain Tumors

A new type of cancer treatment delivered through the nose, rather than by conventional injection, is gaining...